Related Experiment Videos
[Biological standardization of Ginkgo extracts]
B Steinke1, B Müller, H Wagner
1Institut für Pharmazeutische Biologie, Universität München, Federal Republic of Germany.
Planta Medica
|April 1, 1993
Summary
Biological standardization of Ginkgo biloba extracts using platelet aggregation inhibition is feasible. This method, specific for ginkgolides, aligns well with chemical analysis for consistent product quality.
Area of Science:
- Pharmacology
- Natural Product Chemistry
- Biotechnology
Context:
- Ginkgo biloba extracts are widely used, necessitating reliable standardization methods.
- Platelet-activating factor (PAF)-induced platelet aggregation is a key pharmacological effect of ginkgolides.
- Current standardization often relies on chemical analysis, which may not fully capture biological activity.
Purpose:
- To establish and validate a biological standardization method for Ginkgo biloba extracts based on PAF-induced platelet aggregation inhibition.
- To assess the specificity and reliability of this biological assay for ginkgolides (A, B, C, and J).
- To compare the results of biological standardization with traditional chemical-analytical methods.
Summary:
- A biological assay measuring the inhibition of PAF-induced platelet aggregation was developed for Ginkgo biloba extracts.
- The assay is specific for ginkgolides and unaffected by other extract components.
- Equi-effective total ginkgolide content was calculated using IC50 values and chromatographic data, showing good agreement with gas chromatography results.
Impact:
- Demonstrates the feasibility of biological standardization for Ginkgo biloba extracts, complementing chemical methods.
- Provides a method to ensure consistent pharmacological potency of Ginkgo products.
- Enhances quality control for Ginkgo biloba supplements, potentially improving therapeutic efficacy and safety.